Magnetic resonance imaging, pacemakers and implantable cardioverter- defibrillators: Current situation and clinical perspective

Netherlands Heart Journal

Volumn 18, Issue 1, 2010, Pages 31-37

  Gotte M J W ^a   Russel I K ^b   De Roest, G J ^b   Germans, T ^b   Veldkamp, R F ^c   Knaapen, P ^b   Allaart, C P ^b   Van Rossum, A C ^b  

^a HAGA HOSPITAL   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Implantable cardioverter defibrillator; Magnetic resonance imaging; Pacemaker

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL EVALUATION; DEFIBRILLATOR; FOOD AND DRUG ADMINISTRATION; HEART PACING; HUMAN; IN VIVO STUDY; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SAFETY;

EID: 77149160028     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
2. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker selection in the elderly investigators. N Engl J Med. 1998:338:1097-104.
3. Connolly SJ, Kerr C, Gent M, Roberts RS, Yusuf S, Gillis AM, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular cause. Canadian trial of physiologic pacing investigators. N Engl J Med. 2000;342: 1385-91.
4. Silverman BG, Gross TP, Kaczmarek RG, Hamilton P, Hamburger S. The epidemiology of pacemaker implantation in the United States. Public Health Rep. 1995;110:42-6.
5. Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA. 2001;286:793-9.
6. Rieder SJ. MR imaging: Its development and the recent Nobel prize. Radiology. 2004;231:638-41.
7. Grothues F, Smith GS, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29-34.
8. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147:218-23.
9. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006:10: 911-7.
10. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 16:1445-53.
11. Zwanenburg JJM, Gotte MJW, Marcus JT, Kuijer JP, Knaapen P, Heethaar RM, et al. Propagation of onset and peak time of myocardial shortening in time of myocardial shortening in ischemic versus nonischemic cardiomyopathy: assessment by magnetic resonance imaging myocardial tagging. J Am Coll Cardiol. 2005; 46:2215-22.
12. Fayad ZA. The assessment of the vulnerable atherosclerotic plaque using MR imaging: a brief review. Int J Cardiovasc Imaging. 2001;17:165-77.
13. Kalin R, Stanton MS. Current clinical issues for mri scanning of pacemaker and defibrillator patients. Pace. 2005;28:326-8.
14. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace. 2008;10: 336-46.
15. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfield TM, Bluemke DA, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe. In vitro and invivo assessment of safety and function at 1.5T. Circulation. 2004;110:475-82.
16. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5 Teslan mri scanner on cardiac pacemakers and ICD's. Pacing Clin Electrophysiol. 2001;24:199-205.
17. Sommer T, Vahlhaus C, Lauck G, von Smekal A, Reinke M, Hofer U, et al. MRI and cardiac pacemakers: in-vitro evaluation and invivo studies in 51 patients at 0.5T. Radiology. 2000;215:869-79.
18. Duru F, Luechinger R, Candinas R. MRI in patients with cardiac pacemakers. Radiology. 2001;219:856-8.
19. Walton C, Gergely S, Economides AP. Platinum pacemaker electrodes: origins and effects of the electrode-tissue interface impedance. Pacing Clin Electrophysiol. 1987;10:87-99.
20. Luechinger R, Zeijlemaker VA, Morre Pederson E, Mortensen P, Falk E, Duru F, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2004;26:376-83.
21. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315-24.
22. Schmiedel A, Hackenbroch M, Yang A, Nähle CP, Skowasch D, Meyer C, et al. Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla. Rofo. 2005;177:731-44.
23. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285-92.
24. Gimbel JR, Baily SM, Tchou PJ, Ruggieri PM, Wilkoff BL. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. PACE. 2005;28:1041-6.
25. Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable- cardioverter defibrillators at 1.5 Tesla. Circulation. 2006;114:1277-84.
26. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of Magnetic Resonance Imaging (MRI) in Selected Patients with Implantable Cardioverter Defibrillators (ICDs). Pacing Clin Electrophysiol. 2005;28;270-3.
27. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrllators. J Am Coll Card. 2009;54: 549-55.
28. Greatbatch W, Miller V, Shellock FG. Magnetic resonance safety testing of a newly-developed fiber-optic cardiac pacing lead. J Magn Reson Imaging. 2002;16:97-103
29. Sutton R, Kanal E, Wilkoff BL, Bello D, Luechinger R, Jeniskens I, et al. Safety of magnetic resonance imaging of patients with new Medtronic Enrhythm MRI SureScan pacing system: clinical study design. Trials. 2008;68:9;1-8.